Brentuximab-Induced Acute Interstitial Nephritis: A Case Report
Brentuximab vedotin is a combination monoclonal antibody to anti-CD30 conjugated to the anti-tubulin agent monomethyl auristatin E. It is approved for the treatment of mycosis fungoides, Hodgkin’s lymphoma, and systemic anaplastic large cell lymphoma. Brentuximab has been associated with a number of...
Saved in:
| Main Authors: | Matthew Patterson, Pouneh Dokouhaki, Chance S. Dumaine, Rebecca MacKay, Davina J. Tai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Canadian Journal of Kidney Health and Disease |
| Online Access: | https://doi.org/10.1177/20543581241300766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure
by: Matthew Leong, et al.
Published: (2024-11-01) -
Karyomegalic interstitial nephritis
by: Xhamy Martelli Guerrero, et al.
Published: (2024-09-01) -
Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy
by: Antonio Faieta, et al.
Published: (2021-01-01) -
Acute interstitial tubulo nephritis associated with statin treatment
by: Miguel Ángel González Martínez, et al.
Published: (2024-09-01) -
Acute Interstitial Nephritis due to Leptospira grippotyphosa in the Absence of Weil’s Disease
by: Tanja Schmidhauser, et al.
Published: (2013-01-01)